Centene : Amendments to Articles of Incorporation/Bylaws/Change in Fiscal Year - Form 8-K
April 29, 2022 at 05:42 am IST
Share
cnc-20220426
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 26, 2022
CENTENE CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware
001-31826
42-1406317
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
7700 Forsyth Boulevard,
St. Louis,
Missouri
63105
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number, including area code: (314) 725-4477
(Former Name or Former Address, if Changed Since Last Report): N/A
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, $0.001 Par Value
CNC
NYSE
ITEM 5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR
On April 26, 2022, Centene Corporation (the "Company") amended its Amended and Restated Certificate of Incorporation (the "Certificate of Incorporation") to declassify the Board of Directors (the "Board") of the Company over a three year period (the "Charter Amendment") and provide that beginning with the Company's 2023 annual meeting of stockholders, all directors shall be elected for terms expiring at the Company's next annual meeting of stockholders.
The Charter Amendment was previously approved by the Board of Directors (the "Board") of the Company, subject to stockholder approval, and approved by the Company's stockholders at the Company's 2022 Annual Meeting of Stockholders (the "Annual Meeting"), as further described in Item 5.07 below.
Additionally, on April 26, 2022 the Board approved amendments to the Amended and Restated By-Laws of the Company (the "By-Laws") reflecting (i) corresponding changes to the By-Laws related to the Charter Amendment, and (ii) the addition of the position of Chief Executive Officer in the list of officers in Article IV, along with various corresponding changes.
The foregoing description of the Charter Amendment and amendment to the By-Laws does not purport to be complete and is qualified in its entirety by reference to the full text of the Charter Amendment and the Amended and Restated By-Laws, as amended. Copies of the Charter Amendment and the Amended and Restated By-Laws are filed as Exhibits 3.1 and 3.2, respectively, to this Current Report on Form 8-K and incorporated by reference herein.
ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
On April 26, 2022, the Company held its Annual Meeting. There were 537,891,834 shares of common stock represented at the Annual Meeting. The stockholders of the Company voted as follows on the following matters at the Annual Meeting:
1.
Election of Directors.The five directors were elected at the Annual Meeting for a three-year term based upon the following votes:
Director Nominee
For
Against
Abstain
Broker Non-Votes
Orlando Ayala
459,961,145
59,734,913
117,684
18,078,092
Kenneth A. Burdick
510,534,704
8,789,352
489,686
18,078,092
H. James Dallas
417,226,834
102,334,950
251,958
18,078,092
Sarah M. London
512,715,693
6,647,683
450,366
18,078,092
Theodore R. Samuels
512,437,562
7,239,172
137,008
18,078,092
2.
Non-binding advisory vote on executive compensation.The Company's executive compensation was not approved by a non-binding advisory vote based upon the following votes:
For
Against
Abstain
Broker Non-Votes
174,794,813
344,825,680
193,249
18,078,092
3.
Ratification of the appointment of KPMG LLP.The appointment of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2022 was ratified based upon the following votes:
For
Against
Abstain
529,357,743
8,408,800
125,291
4.
Approval of Amendment to the Company's Amended and Restated Certificate of Incorporation to declassify the Board.The approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to declassify the Board was approved based upon the following votes:
For
Against
Abstain
Broker Non-Votes
518,943,045
735,230
135,467
18,078,092
5.
Board proposal regarding stockholder right to call for a special stockholder meeting.The Board's proposal was not approved based upon the following votes:
For
Against
Abstain
Broker Non-Votes
246,155,069
273,243,772
414,901
18,078,092
6.
Shareholder proposal regarding the shareholder right to call for a special shareholder meeting.The shareholder proposal was approved based upon the following votes:
Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CENTENE CORPORATION
Date:
April 28, 2022
By:
/s/ Christopher A. Koster
Christopher A. Koster
Executive Vice President, Secretary and General Counsel
Attachments
Original Link
Original Document
Permalink
Disclaimer
Centene Corporation published this content on 28 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 April 2022 00:11:11 UTC.
Centene Corporation specializes in health services. Revenues break down by activity as follows:
- development of health insurance programs (91%): primarily for children, pregnant women, blind and disabled persons;
- specialized services (9%): pharmaceutical services (claims processing, pharmacy network management, mail order sales, home delivery, analysis and clinical consulting services, etc.), health care services by education and empowerment (behavioral orientation programs and welfare, nursing advice, etc.), eye and dental care services, home care services, development of health care management solutions, etc.